Pipobroman

Pipobroman (Vercyte) is an alkylating agent with established clinical efficacy in polycythemia vera and essential thrombocythemia, achieving high response rates with a favorable long-term risk profile for thrombosis and leukemic transformation. Its research applications include in vitro studies on hematopoietic cell lines and in vivo models of myeloproliferative neoplasms to investigate its antiproliferative mechanisms.